241 related articles for article (PubMed ID: 35022570)
1. YB-1 is a positive regulator of KLF5 transcription factor in basal-like breast cancer.
Jiang D; Qiu T; Peng J; Li S; Tala ; Ren W; Yang C; Wen Y; Chen CH; Sun J; Wu Y; Liu R; Zhou J; Wu K; Liu W; Mao X; Zhou Z; Chen C
Cell Death Differ; 2022 Jun; 29(6):1283-1295. PubMed ID: 35022570
[TBL] [Abstract][Full Text] [Related]
2. Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells.
Stratford AL; Fry CJ; Desilets C; Davies AH; Cho YY; Li Y; Dong Z; Berquin IM; Roux PP; Dunn SE
Breast Cancer Res; 2008; 10(6):R99. PubMed ID: 19036157
[TBL] [Abstract][Full Text] [Related]
3. A feedforward circuit between KLF5 and lncRNA KPRT4 contributes to basal-like breast cancer.
Du G; Sun J; Li Z; Zhang Q; Liu W; Yang C; Zhao P; Wang X; Yin Q; Luo Y; Song J; Wen Y; Wang H; Chen CH; Hu G; Zhou Z; Mao X; Liu W; Liu Z; Jiang D; Chen C
Cancer Lett; 2022 May; 534():215618. PubMed ID: 35259457
[TBL] [Abstract][Full Text] [Related]
4. Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1).
Reipas KM; Law JH; Couto N; Islam S; Li Y; Li H; Cherkasov A; Jung K; Cheema AS; Jones SJ; Hassell JA; Dunn SE
Oncotarget; 2013 Feb; 4(2):329-45. PubMed ID: 23593654
[TBL] [Abstract][Full Text] [Related]
5. Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.
Zheng HQ; Zhou Z; Huang J; Chaudhury L; Dong JT; Chen C
Oncogene; 2009 Oct; 28(42):3702-13. PubMed ID: 19668233
[TBL] [Abstract][Full Text] [Related]
6. Arginine methyltransferase PRMT5 methylates and stabilizes KLF5 via decreasing its phosphorylation and ubiquitination to promote basal-like breast cancer.
Wang X; Qiu T; Wu Y; Yang C; Li Y; Du G; He Y; Liu W; Liu R; Chen CH; Shi Y; Pan J; Zhou J; Jiang D; Chen C
Cell Death Differ; 2021 Oct; 28(10):2931-2945. PubMed ID: 33972717
[TBL] [Abstract][Full Text] [Related]
7. Cell fate factor DACH1 represses YB-1-mediated oncogenic transcription and translation.
Wu K; Chen K; Wang C; Jiao X; Wang L; Zhou J; Wang J; Li Z; Addya S; Sorensen PH; Lisanti MP; Quong A; Ertel A; Pestell RG
Cancer Res; 2014 Feb; 74(3):829-39. PubMed ID: 24335958
[TBL] [Abstract][Full Text] [Related]
8. Targeting p90 ribosomal S6 kinase eliminates tumor-initiating cells by inactivating Y-box binding protein-1 in triple-negative breast cancers.
Stratford AL; Reipas K; Hu K; Fotovati A; Brough R; Frankum J; Takhar M; Watson P; Ashworth A; Lord CJ; Lasham A; Print CG; Dunn SE
Stem Cells; 2012 Jul; 30(7):1338-48. PubMed ID: 22674792
[TBL] [Abstract][Full Text] [Related]
9. Targeting the KLF5-EphA2 axis can restrain cancer stemness and overcome chemoresistance in basal-like breast cancer.
Zhao P; Sun J; Huang X; Zhang X; Liu X; Liu R; Du G; Gan W; Yang C; Tang Y; Chen C; Jiang D
Int J Biol Sci; 2023; 19(6):1861-1874. PubMed ID: 37063424
[TBL] [Abstract][Full Text] [Related]
10. Histone Deacetylase Inhibitors (HDACi) Promote KLF5 Ubiquitination and Degradation in Basal-like Breast Cancer.
Kong Y; Ren W; Fang H; Shah NA; Shi Y; You D; Zhou C; Jiang D; Yang C; Liang H; Liu W; Wang L; Gan W; Wan X; Li F; Li Z; Chen C; Xie N
Int J Biol Sci; 2022; 18(5):2104-2115. PubMed ID: 35342356
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of super enhancer downregulates the expression of KLF5 in basal-like breast cancers.
Chen CH; Yang N; Zhang Y; Ding J; Zhang W; Liu R; Liu W; Chen C
Int J Biol Sci; 2019; 15(8):1733-1742. PubMed ID: 31360115
[TBL] [Abstract][Full Text] [Related]
12. KLF5 promotes breast cell survival partially through fibroblast growth factor-binding protein 1-pERK-mediated dual specificity MKP-1 protein phosphorylation and stabilization.
Liu R; Zheng HQ; Zhou Z; Dong JT; Chen C
J Biol Chem; 2009 Jun; 284(25):16791-16798. PubMed ID: 19411256
[TBL] [Abstract][Full Text] [Related]
13. KLF5-induced lncRNA IGFL2-AS1 promotes basal-like breast cancer cell growth and survival by upregulating the expression of IGFL1.
Wang H; Shi Y; Chen CH; Wen Y; Zhou Z; Yang C; Sun J; Du G; Wu J; Mao X; Liu R; Chen C
Cancer Lett; 2021 Sep; 515():49-62. PubMed ID: 34052325
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy.
Stratford AL; Habibi G; Astanehe A; Jiang H; Hu K; Park E; Shadeo A; Buys TP; Lam W; Pugh T; Marra M; Nielsen TO; Klinge U; Mertens PR; Aparicio S; Dunn SE
Breast Cancer Res; 2007; 9(5):R61. PubMed ID: 17875215
[TBL] [Abstract][Full Text] [Related]
15. YAP promotes breast cell proliferation and survival partially through stabilizing the KLF5 transcription factor.
Zhi X; Zhao D; Zhou Z; Liu R; Chen C
Am J Pathol; 2012 Jun; 180(6):2452-61. PubMed ID: 22632819
[TBL] [Abstract][Full Text] [Related]
16. Cell fate determination factor Dachshund reprograms breast cancer stem cell function.
Wu K; Jiao X; Li Z; Katiyar S; Casimiro MC; Yang W; Zhang Q; Willmarth NE; Chepelev I; Crosariol M; Wei Z; Hu J; Zhao K; Pestell RG
J Biol Chem; 2011 Jan; 286(3):2132-42. PubMed ID: 20937839
[TBL] [Abstract][Full Text] [Related]
17. BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5.
Qin J; Zhou Z; Chen W; Wang C; Zhang H; Ge G; Shao M; You D; Fan Z; Xia H; Liu R; Chen C
Nat Commun; 2015 Sep; 6():8471. PubMed ID: 26419610
[TBL] [Abstract][Full Text] [Related]
18. The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation.
Liu R; Zhou Z; Zhao D; Chen C
Mol Endocrinol; 2011 Jul; 25(7):1137-44. PubMed ID: 21566082
[TBL] [Abstract][Full Text] [Related]
19. Kruppel-like factor 5 transcription factor promotes microsomal prostaglandin E2 synthase 1 gene transcription in breast cancer.
Xia H; Wang C; Chen W; Zhang H; Chaudhury L; Zhou Z; Liu R; Chen C
J Biol Chem; 2013 Sep; 288(37):26731-40. PubMed ID: 23913682
[TBL] [Abstract][Full Text] [Related]
20. The phosphoinositide-dependent kinase-1 inhibitor 2-amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-acetamide (OSU-03012) prevents Y-box binding protein-1 from inducing epidermal growth factor receptor.
To K; Zhao Y; Jiang H; Hu K; Wang M; Wu J; Lee C; Yokom DW; Stratford AL; Klinge U; Mertens PR; Chen CS; Bally M; Yapp D; Dunn SE
Mol Pharmacol; 2007 Sep; 72(3):641-52. PubMed ID: 17595327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]